Compare stocks

COLTENE Holding AG is a Swiss company operating in the dental industry, providing a broad range of products and services for dental practitioners and laboratories. The company's core offerings include dental consumables, tools, and equipment that support restoration, endodontics, and treatment hygiene. Headquartered in Altstätten, Switzerland, COLTENE serves a global customer base with manufacturing sites in Switzerland, Germany, the USA, and Hungary. The company's strategic positioning is enhanced by its focus on innovative dental solutions and its extensive product portfolio, catering to various aspects of dental care and procedures.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.